Study Of Sunitinib In Combination With Folfox In Patients With Colorectal Cancer
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
To assess the safety and tolerability of sunitinib when administered in combination with
modified FOLFOX6 in Japanese patients with metastatic colorectal cancer in the first-line
treatment setting.